Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

276
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

353
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

303
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
303
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

359
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
359
Interdisciplinary Care: The Health Care Team-I01:21

Interdisciplinary Care: The Health Care Team-I

2.8K
An interdisciplinary team includes many healthcare professionals working together and utilizing their skills, knowledge, and expertise to provide holistic and quality patient care.
Physicians
The physician's primary responsibility is to diagnose illness and direct the medical or surgical treatment of the condition. The authority to admit patients to a healthcare agency or institution and practice care within that setting is granted to physicians by the healthcare agency or institution...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health Mindset in Pediatric Inflammatory Bowel Disease: Exploring the Relationship Between Health Mindset and Key Physical and Psychosocial Outcomes.

Children (Basel, Switzerland)·2026
Same author

Participant experiences of the Knee Care for Arthritis through Pharmacy Service (KneeCAPS): A personalised hīkoi (journey) through care.

Osteoarthritis and cartilage open·2026
Same author

Correction: Feasibility of conducting a pilot randomized trial of a mindfulness-based intervention among sheltered young adults experiencing homelessness.

Frontiers in psychology·2026
Same author

Mindfulness-Based Interventions for Adolescent Substance Use and Substance Use Disorders: A Systematic Review.

Pediatrics·2026
Same author

Feasibility of conducting a pilot randomized trial of a mindfulness-based intervention among sheltered young adults experiencing homelessness.

Frontiers in psychology·2025
Same author

Live Video MBSR is a Feasible and Acceptable Adjunctive Therapy for Youth With Inflammatory Bowel Disease.

Global advances in integrative medicine and health·2025
Same journal

Influenza Vaccine Effectiveness Against Pediatric Death in the United States: 2016-2025.

Pediatrics·2026
Same journal

Averting the Unthinkable: Immunization to Prevent Childhood Deaths From Influenza.

Pediatrics·2026
Same journal

Severe Postoperative Hypernatremia in an Adolescent Following Sleeve Gastrectomy.

Pediatrics·2026
Same journal

Barriers to Implementing SMART for Asthma in Pediatric Primary Care.

Pediatrics·2026
Same journal

Blood Lead Testing Among Children Enrolled in Medicaid.

Pediatrics·2026
Same journal

From Screening to Support: Crafting Social Needs Response Systems That Work for Families.

Pediatrics·2026
See all related articles

Related Experiment Video

Updated: Feb 23, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

15.4K

Pediatric Integrative Medicine.

Hilary McClafferty, Sunita Vohra, Michelle Bailey

    Pediatrics
    |August 30, 2017
    PubMed
    Summary
    This summary is machine-generated.

    The American Academy of Pediatrics offers updated guidance on complementary and integrative therapies for children. This report aids pediatricians in discussing these treatments with families.

    More Related Videos

    Guidelines for Elective Pediatric Fiberoptic Intubation
    11:19

    Guidelines for Elective Pediatric Fiberoptic Intubation

    Published on: January 17, 2011

    18.7K
    Author Spotlight: Exploring the Potential of Massage Therapy in Cerebral Palsy Using Animal Models
    08:24

    Author Spotlight: Exploring the Potential of Massage Therapy in Cerebral Palsy Using Animal Models

    Published on: August 11, 2023

    2.7K

    Related Experiment Videos

    Last Updated: Feb 23, 2026

    Whole-body PET/MRI of Pediatric Patients: The Details That Matter
    10:02

    Whole-body PET/MRI of Pediatric Patients: The Details That Matter

    Published on: December 19, 2017

    15.4K
    Guidelines for Elective Pediatric Fiberoptic Intubation
    11:19

    Guidelines for Elective Pediatric Fiberoptic Intubation

    Published on: January 17, 2011

    18.7K
    Author Spotlight: Exploring the Potential of Massage Therapy in Cerebral Palsy Using Animal Models
    08:24

    Author Spotlight: Exploring the Potential of Massage Therapy in Cerebral Palsy Using Animal Models

    Published on: August 11, 2023

    2.7K

    Area of Science:

    • Pediatrics and Child Health
    • Integrative and Complementary Medicine

    Background:

    • Increasing use of complementary and integrative therapies (CIT) in pediatric care.
    • Need for reliable information and clinical resources for pediatricians regarding CIT.
    • This report updates the 2008 statement on complementary medicine.

    Purpose of the Study:

    • To provide pediatricians with updated information on CIT for children.
    • To define terms, describe usage epidemiology, and outline common CIT types.
    • To review medicolegal, ethical, and research implications of CIT in pediatrics.

    Main Methods:

    • Review of current literature and clinical practices related to pediatric CIT.
    • Development of educational resources and communication strategies for healthcare providers.
    • Focus on providing a framework for understanding and discussing CIT, rather than an exhaustive list of therapies.

    Main Results:

    • Comprehensive overview of the landscape of CIT used in pediatric populations.
    • Identification of key considerations for pediatricians, including ethical and legal aspects.
    • Provision of resources to support informed clinical decision-making and patient counseling.

    Conclusions:

    • Pediatricians require updated guidance to effectively address the use of CIT with families.
    • This report equips healthcare providers with knowledge on CIT, its implications, and communication strategies.
    • Emphasis on supporting family-centered care through informed discussions about complementary and integrative therapies.